Detalles de la búsqueda
1.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Oncologist
; 29(5): e622-e634, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175669
2.
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
Eur J Nucl Med Mol Imaging
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587643
3.
Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies.
Alzheimers Dement
; 20(4): 2485-2496, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329197
4.
Sex differences in brain atrophy in dementia with Lewy bodies.
Alzheimers Dement
; 20(3): 1815-1826, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131463
5.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625938
6.
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer.
Breast Cancer Res
; 23(1): 42, 2021 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785053
7.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838010
8.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res
; 22(1): 45, 2020 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404150
9.
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Breast Cancer Res
; 21(1): 108, 2019 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533777
10.
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
Oncologist
; 24(7): 893-900, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679318
11.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36809405
12.
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
Lancet Oncol
; 18(4): 545-554, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28238593
13.
Incidence of Norovirus-Associated Diarrhea and Vomiting Disease Among Children and Adults in a Community Cohort in the Peruvian Amazon Basin.
Clin Infect Dis
; 65(5): 833-839, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29017284
14.
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
Clin Chem
; 63(3): 751-760, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28073897
15.
Degeneration of the cholinergic system in individuals with subjective cognitive decline: A systematic review.
Neurosci Biobehav Rev
; 157: 105534, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38220033
16.
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
NPJ Breast Cancer
; 10(1): 20, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448600
17.
Biomarkers of Alzheimer's Disease and Cerebrovascular Disease in Relation to Depressive Symptomatology in Individuals With Subjective Cognitive Decline.
J Gerontol A Biol Sci Med Sci
; 79(2)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708068
18.
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
Carcinogenesis
; 34(2): 268-76, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23108190
19.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
J Natl Cancer Inst
; 115(3): 332-336, 2023 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36576009
20.
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab.
JAMA Oncol
; 9(6): 835-840, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37103927